Lyell Immunopharma, Inc. (LYEL)

23.80 +0.47 (+2.01%) USD  |  NASDAQ  |  Mar 04, 16:00
23.88 +0.08 (+0.34%) After-Hours: 20:00
More

Lyell Immunopharma Average Diluted Shares Outstanding (Annual)

Average Diluted Shares Outstanding (Annual) Chart

View Average Diluted Shares Outstanding (Annual) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Annual) Range, Past 5 Years

View Average Diluted Shares Outstanding (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Annual) Benchmarks

View Average Diluted Shares Outstanding (Annual) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade